Sinnamon, Andrew J <br/><br/>
Interpreting the Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma-Reply.  [electronic resource] 

 -  JAMA oncology  08 2018 
 - 1136-1137 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>2374-2445 
<br/><br/><label>Standard No.: </label>10.1001/jamaoncol.2018.0898  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Humans<br/>Melanoma<br/>Skin Neoplasms